Table 6.
Exposure | ASD Cases (N = 407) n(%) |
Controls (N=2075) n (%) |
Crude OR (95% CI) | OR adj* (95% CI) |
---|---|---|---|---|
Unexposed group** | 199 (48.9) | 1080 (52.0) | reference | reference |
Any infection | ||||
Pregnancy period1 | 64 (15.7) | 249 (12.0) | 1.39 (1.02 – 1.91) | 1.48 (1.07 – 2.04) |
1st Trimester | 2 (0.5) | 1 (0.0) | - | - |
2nd Trimester | 6 (1.5) | 11 (0.5) | 2.96 (1.08 – 8.10) | 3.80 (1.31 – 11.08) |
3rd Trimester | 59 (14.5) | 242 (11.7) | 1.32 (0.96 – 1.83) | 1.39 (1.0 – 1.94) |
Bacterial Infection | ||||
Pregnancy period1 | 38 (9.3) | 150 (7.2) | 1.38 (0.93 – 2.03) | 1.58 (1.06 – 2.37) |
1st Trimester | 0 | 1 | - | - |
2nd Trimester | 4 (0.9) | 8 (0.4) | - | - |
3rd Trimester | 35 (8.6) | 144 (6.9) | 1.32 (0.89 – 1.97) | 1.50 (1.00 – 2.27) |
All ORs were adjusted for the matching variables (child sex, year of birth and hospital of birth) in addition to maternal age and race/ethnicity.
The unexposed group had no diagnosed infections during the period from 30 days before pregnancy to delivery.
The pregnancy period is defined as the time between the LMP and the date of delivery.